Global COPD Therapeutics Market Growth (Status and Outlook) 2022-2028
- LP 4759461
- 64 Pages
- January 2022
- Pharmaceuticals
The United States COPD Therapeutics market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global COPD Therapeutics market, reaching US$ million by the year 2028. As for the Europe COPD Therapeutics landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main COPD Therapeutics players cover GlaxoSmithKline, AstraZeneca, Theravance Biopharma, and Mylan, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of COPD Therapeutics market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Bronchodilators
Inhaled Corticosteroids
Other
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Adult
Child
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
GlaxoSmithKline
AstraZeneca
Theravance Biopharma
Mylan
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global COPD Therapeutics Market Size 2017-2028
2.1.2 COPD Therapeutics Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 COPD Therapeutics Segment by Type
2.2.1 Bronchodilators
2.2.2 Inhaled Corticosteroids
2.2.3 Other
2.3 COPD Therapeutics Market Size by Type
2.3.1 COPD Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global COPD Therapeutics Market Size Market Share by Type (2017-2022)
2.4 COPD Therapeutics Segment by Application
2.4.1 Adult
2.4.2 Child
2.5 COPD Therapeutics Market Size by Application
2.5.1 COPD Therapeutics Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global COPD Therapeutics Market Size Market Share by Application (2017-2022)
3 COPD Therapeutics Market Size by Player
3.1 COPD Therapeutics Market Size Market Share by Players
3.1.1 Global COPD Therapeutics Revenue by Players (2020-2022)
3.1.2 Global COPD Therapeutics Revenue Market Share by Players (2020-2022)
3.2 Global COPD Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 COPD Therapeutics by Regions
4.1 COPD Therapeutics Market Size by Regions (2017-2022)
4.2 Americas COPD Therapeutics Market Size Growth (2017-2022)
4.3 APAC COPD Therapeutics Market Size Growth (2017-2022)
4.4 Europe COPD Therapeutics Market Size Growth (2017-2022)
4.5 Middle East & Africa COPD Therapeutics Market Size Growth (2017-2022)
5 Americas
5.1 Americas COPD Therapeutics Market Size by Country (2017-2022)
5.2 Americas COPD Therapeutics Market Size by Type (2017-2022)
5.3 Americas COPD Therapeutics Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC COPD Therapeutics Market Size by Region (2017-2022)
6.2 APAC COPD Therapeutics Market Size by Type (2017-2022)
6.3 APAC COPD Therapeutics Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe COPD Therapeutics by Country (2017-2022)
7.2 Europe COPD Therapeutics Market Size by Type (2017-2022)
7.3 Europe COPD Therapeutics Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa COPD Therapeutics by Region (2017-2022)
8.2 Middle East & Africa COPD Therapeutics Market Size by Type (2017-2022)
8.3 Middle East & Africa COPD Therapeutics Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global COPD Therapeutics Market Forecast
10.1 Global COPD Therapeutics Forecast by Regions (2023-2028)
10.1.1 Global COPD Therapeutics Forecast by Regions (2023-2028)
10.1.2 Americas COPD Therapeutics Forecast
10.1.3 APAC COPD Therapeutics Forecast
10.1.4 Europe COPD Therapeutics Forecast
10.1.5 Middle East & Africa COPD Therapeutics Forecast
10.2 Americas COPD Therapeutics Forecast by Country (2023-2028)
10.2.1 United States COPD Therapeutics Market Forecast
10.2.2 Canada COPD Therapeutics Market Forecast
10.2.3 Mexico COPD Therapeutics Market Forecast
10.2.4 Brazil COPD Therapeutics Market Forecast
10.3 APAC COPD Therapeutics Forecast by Region (2023-2028)
10.3.1 China COPD Therapeutics Market Forecast
10.3.2 Japan COPD Therapeutics Market Forecast
10.3.3 Korea COPD Therapeutics Market Forecast
10.3.4 Southeast Asia COPD Therapeutics Market Forecast
10.3.5 India COPD Therapeutics Market Forecast
10.3.6 Australia COPD Therapeutics Market Forecast
10.4 Europe COPD Therapeutics Forecast by Country (2023-2028)
10.4.1 Germany COPD Therapeutics Market Forecast
10.4.2 France COPD Therapeutics Market Forecast
10.4.3 UK COPD Therapeutics Market Forecast
10.4.4 Italy COPD Therapeutics Market Forecast
10.4.5 Russia COPD Therapeutics Market Forecast
10.5 Middle East & Africa COPD Therapeutics Forecast by Region (2023-2028)
10.5.1 Egypt COPD Therapeutics Market Forecast
10.5.2 South Africa COPD Therapeutics Market Forecast
10.5.3 Israel COPD Therapeutics Market Forecast
10.5.4 Turkey COPD Therapeutics Market Forecast
10.5.5 GCC Countries COPD Therapeutics Market Forecast
10.6 Global COPD Therapeutics Forecast by Type (2023-2028)
10.7 Global COPD Therapeutics Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Information
11.1.2 GlaxoSmithKline COPD Therapeutics Product Offered
11.1.3 GlaxoSmithKline COPD Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 GlaxoSmithKline Main Business Overview
11.1.5 GlaxoSmithKline Latest Developments
11.2 AstraZeneca
11.2.1 AstraZeneca Company Information
11.2.2 AstraZeneca COPD Therapeutics Product Offered
11.2.3 AstraZeneca COPD Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 AstraZeneca Main Business Overview
11.2.5 AstraZeneca Latest Developments
11.3 Theravance Biopharma
11.3.1 Theravance Biopharma Company Information
11.3.2 Theravance Biopharma COPD Therapeutics Product Offered
11.3.3 Theravance Biopharma COPD Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Theravance Biopharma Main Business Overview
11.3.5 Theravance Biopharma Latest Developments
11.4 Mylan
11.4.1 Mylan Company Information
11.4.2 Mylan COPD Therapeutics Product Offered
11.4.3 Mylan COPD Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Mylan Main Business Overview
11.4.5 Mylan Latest Developments
12 Research Findings and Conclusion
Table 1. COPD Therapeutics Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Bronchodilators
Table 3. Major Players of Inhaled Corticosteroids
Table 4. Major Players of Other
Table 5. COPD Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 6. Global COPD Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 7. Global COPD Therapeutics Market Size Market Share by Type (2017-2022)
Table 8. COPD Therapeutics Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 9. Global COPD Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 10. Global COPD Therapeutics Market Size Market Share by Application (2017-2022)
Table 11. Global COPD Therapeutics Revenue by Players (2020-2022) & ($ Millions)
Table 12. Global COPD Therapeutics Revenue Market Share by Player (2020-2022)
Table 13. COPD Therapeutics Key Players Head office and Products Offered
Table 14. COPD Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global COPD Therapeutics Market Size by Regions 2017-2022 & ($ Millions)
Table 18. Global COPD Therapeutics Market Size Market Share by Regions (2017-2022)
Table 19. Americas COPD Therapeutics Market Size by Country (2017-2022) & ($ Millions)
Table 20. Americas COPD Therapeutics Market Size Market Share by Country (2017-2022)
Table 21. Americas COPD Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 22. Americas COPD Therapeutics Market Size Market Share by Type (2017-2022)
Table 23. Americas COPD Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 24. Americas COPD Therapeutics Market Size Market Share by Application (2017-2022)
Table 25. APAC COPD Therapeutics Market Size by Region (2017-2022) & ($ Millions)
Table 26. APAC COPD Therapeutics Market Size Market Share by Region (2017-2022)
Table 27. APAC COPD Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 28. APAC COPD Therapeutics Market Size Market Share by Type (2017-2022)
Table 29. APAC COPD Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 30. APAC COPD Therapeutics Market Size Market Share by Application (2017-2022)
Table 31. Europe COPD Therapeutics Market Size by Country (2017-2022) & ($ Millions)
Table 32. Europe COPD Therapeutics Market Size Market Share by Country (2017-2022)
Table 33. Europe COPD Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 34. Europe COPD Therapeutics Market Size Market Share by Type (2017-2022)
Table 35. Europe COPD Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 36. Europe COPD Therapeutics Market Size Market Share by Application (2017-2022)
Table 37. Middle East & Africa COPD Therapeutics Market Size by Region (2017-2022) & ($ Millions)
Table 38. Middle East & Africa COPD Therapeutics Market Size Market Share by Region (2017-2022)
Table 39. Middle East & Africa COPD Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 40. Middle East & Africa COPD Therapeutics Market Size Market Share by Type (2017-2022)
Table 41. Middle East & Africa COPD Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 42. Middle East & Africa COPD Therapeutics Market Size Market Share by Application (2017-2022)
Table 43. Key Market Drivers & Growth Opportunities of COPD Therapeutics
Table 44. Key Market Challenges & Risks of COPD Therapeutics
Table 45. Key Industry Trends of COPD Therapeutics
Table 46. Global COPD Therapeutics Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 47. Global COPD Therapeutics Market Size Market Share Forecast by Regions (2023-2028)
Table 48. Global COPD Therapeutics Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 49. Global COPD Therapeutics Market Size Market Share Forecast by Type (2023-2028)
Table 50. Global COPD Therapeutics Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 51. Global COPD Therapeutics Market Size Market Share Forecast by Application (2023-2028)
Table 52. GlaxoSmithKline Details, Company Type, COPD Therapeutics Area Served and Its Competitors
Table 53. GlaxoSmithKline COPD Therapeutics Product Offered
Table 54. GlaxoSmithKline COPD Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 55. GlaxoSmithKline Main Business
Table 56. GlaxoSmithKline Latest Developments
Table 57. AstraZeneca Details, Company Type, COPD Therapeutics Area Served and Its Competitors
Table 58. AstraZeneca COPD Therapeutics Product Offered
Table 59. AstraZeneca Main Business
Table 60. AstraZeneca COPD Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 61. AstraZeneca Latest Developments
Table 62. Theravance Biopharma Details, Company Type, COPD Therapeutics Area Served and Its Competitors
Table 63. Theravance Biopharma COPD Therapeutics Product Offered
Table 64. Theravance Biopharma Main Business
Table 65. Theravance Biopharma COPD Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 66. Theravance Biopharma Latest Developments
Table 67. Mylan Details, Company Type, COPD Therapeutics Area Served and Its Competitors
Table 68. Mylan COPD Therapeutics Product Offered
Table 69. Mylan Main Business
Table 70. Mylan COPD Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 71. Mylan Latest Developments
List of Figures
Figure 1. COPD Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global COPD Therapeutics Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global COPD Therapeutics Market Size Market Share by Type in 2021
Figure 7. COPD Therapeutics in Adult
Figure 8. Global COPD Therapeutics Market: Adult (2017-2022) & ($ Millions)
Figure 9. COPD Therapeutics in Child
Figure 10. Global COPD Therapeutics Market: Child (2017-2022) & ($ Millions)
Figure 11. Global COPD Therapeutics Market Size Market Share by Application in 2021
Figure 12. Global COPD Therapeutics Revenue Market Share by Player in 2021
Figure 13. Global COPD Therapeutics Market Size Market Share by Regions (2017-2022)
Figure 14. Americas COPD Therapeutics Market Size 2017-2022 ($ Millions)
Figure 15. APAC COPD Therapeutics Market Size 2017-2022 ($ Millions)
Figure 16. Europe COPD Therapeutics Market Size 2017-2022 ($ Millions)
Figure 17. Middle East & Africa COPD Therapeutics Market Size 2017-2022 ($ Millions)
Figure 18. Americas COPD Therapeutics Value Market Share by Country in 2021
Figure 19. Americas COPD Therapeutics Consumption Market Share by Type in 2021
Figure 20. Americas COPD Therapeutics Market Size Market Share by Application in 2021
Figure 21. United States COPD Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 22. Canada COPD Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 23. Mexico COPD Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 24. Brazil COPD Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 25. APAC COPD Therapeutics Market Size Market Share by Region in 2021
Figure 26. APAC COPD Therapeutics Market Size Market Share by Application in 2021
Figure 27. China COPD Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 28. Japan COPD Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 29. Korea COPD Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 30. Southeast Asia COPD Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 31. India COPD Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 32. Australia COPD Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 33. Europe COPD Therapeutics Market Size Market Share by Country in 2021
Figure 34. Europe COPD Therapeutics Market Size Market Share by Type in 2021
Figure 35. Europe COPD Therapeutics Market Size Market Share by Application in 2021
Figure 36. Germany COPD Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 37. France COPD Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 38. UK COPD Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 39. Italy COPD Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 40. Russia COPD Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 41. Middle East & Africa COPD Therapeutics Market Size Market Share by Region in 2021
Figure 42. Middle East & Africa COPD Therapeutics Market Size Market Share by Type in 2021
Figure 43. Middle East & Africa COPD Therapeutics Market Size Market Share by Application in 2021
Figure 44. Egypt COPD Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 45. South Africa COPD Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 46. Israel COPD Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 47. Turkey COPD Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 48. GCC Country COPD Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 49. Americas COPD Therapeutics Market Size 2023-2028 ($ Millions)
Figure 50. APAC COPD Therapeutics Market Size 2023-2028 ($ Millions)
Figure 51. Europe COPD Therapeutics Market Size 2023-2028 ($ Millions)
Figure 52. Middle East & Africa COPD Therapeutics Market Size 2023-2028 ($ Millions)
Figure 53. United States COPD Therapeutics Market Size 2023-2028 ($ Millions)
Figure 54. Canada COPD Therapeutics Market Size 2023-2028 ($ Millions)
Figure 55. Mexico COPD Therapeutics Market Size 2023-2028 ($ Millions)
Figure 56. Brazil COPD Therapeutics Market Size 2023-2028 ($ Millions)
Figure 57. China COPD Therapeutics Market Size 2023-2028 ($ Millions)
Figure 58. Japan COPD Therapeutics Market Size 2023-2028 ($ Millions)
Figure 59. Korea COPD Therapeutics Market Size 2023-2028 ($ Millions)
Figure 60. Southeast Asia COPD Therapeutics Market Size 2023-2028 ($ Millions)
Figure 61. India COPD Therapeutics Market Size 2023-2028 ($ Millions)
Figure 62. Australia COPD Therapeutics Market Size 2023-2028 ($ Millions)
Figure 63. Germany COPD Therapeutics Market Size 2023-2028 ($ Millions)
Figure 64. France COPD Therapeutics Market Size 2023-2028 ($ Millions)
Figure 65. UK COPD Therapeutics Market Size 2023-2028 ($ Millions)
Figure 66. Italy COPD Therapeutics Market Size 2023-2028 ($ Millions)
Figure 67. Russia COPD Therapeutics Market Size 2023-2028 ($ Millions)
Figure 68. Spain COPD Therapeutics Market Size 2023-2028 ($ Millions)
Figure 69. Egypt COPD Therapeutics Market Size 2023-2028 ($ Millions)
Figure 70. South Africa COPD Therapeutics Market Size 2023-2028 ($ Millions)
Figure 71. Israel COPD Therapeutics Market Size 2023-2028 ($ Millions)
Figure 72. Turkey COPD Therapeutics Market Size 2023-2028 ($ Millions)
Figure 73. GCC Countries COPD Therapeutics Market Size 2023-2028 ($ Millions)
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
